NASDAQ:TNDM - Tandem Diabetes Care Stock Price, Price Target & More

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

Shares of Tandem Diabetes Care reverse split on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

Tandem Diabetes Care Inc (NASDAQ:TNDM) issued its quarterly earnings data on Thursday, March, 1st. The medical device company reported ($1.23) earnings per share for the quarter, missing the consensus estimate of ($1.11) by $0.13. The medical device company earned $40 million during the quarter, compared to analyst estimates of $38.41 million. The firm's revenue was up 61.3% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.48) earnings per share. View Tandem Diabetes Care's Earnings History.

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Tandem Diabetes Care.

9 brokerages have issued 12 month price targets for Tandem Diabetes Care's shares. Their predictions range from $3.00 to $30.00. On average, they anticipate Tandem Diabetes Care's share price to reach $15.4375 in the next year. This suggests that the stock has a possible downside of 41.8%. View Analyst Ratings for Tandem Diabetes Care.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tandem Diabetes Care in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Tandem Diabetes Care saw a increase in short interest during the month of June. As of June 29th, there was short interest totalling 5,883,644 shares, an increase of 111.5% from the June 15th total of 2,782,413 shares. Based on an average daily trading volume, of 4,761,328 shares, the days-to-cover ratio is presently 1.2 days. Approximately 14.7% of the company's stock are short sold. View Tandem Diabetes Care's Current Options Chain.

Some companies that are related to Tandem Diabetes Care include Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE), Penumbra (PEN), Cantel Medical (CMD), Novocure (NVCR), Merit Medical Systems (MMSI), NuVasive (NUVA), Irhythm Technologies (IRTC), Nevro (NVRO), Mazor Robotics (MZOR), Glaukos (GKOS), Luminex (LMNX), Cardiovascular Systems (CSII) and Atrion (ATRI).

News stories about TNDM stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tandem Diabetes Care earned a daily sentiment score of 0.13 on Accern's scale. They also gave news articles about the medical device company an impact score of 46.45 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Shares of TNDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TNDM stock can currently be purchased for approximately $26.53.

Tandem Diabetes Care has a market capitalization of $1.30 billion and generates $107.60 million in revenue each year. The medical device company earns $-73,030,000.00 in net income (profit) each year or ($12.87) on an earnings per share basis. Tandem Diabetes Care employs 574 workers across the globe.

Tandem Diabetes Care's mailing address is 11075 ROSELLE STREET, San Diego CA, 92121. The medical device company can be reached via phone at 858-366-6900 or via email at [email protected]